TinyGemsBreaks – GEMXX Corporation (GEMZ) Releases Report of First 2023 Season Gold Production from Snow Creek Mine Site

GEMXX (OTC: GEMZ), a leader in the Ammolite gemstone mine-to-market segment, is reporting the successful completion of its first clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining season. GEMXX is working in collaboration with Crazy Horse Mining Inc. (“CHMI”) on the Snow Creek Mine project. According to the announcement, the two companies have processed a 4,500-cubic-yard sample of gold-bearing surface ore stockpiled while building the processing site, thereby providing a “positive indication of the resource potential on the property.” The company noted that initial production results, which have yielded 38.73 ounces of gold from 4,500 cubic yards of surface material, amounting to 0.86 ounces per 100 cubic yards, exceeded expectations and are indicative of a highly lucrative first year of gold mining.

The company now anticipates ramping up processing to approximately 1,000 cubic yards of gold-bearing ore per day. A Canadian Junior resource company, Crazy Horse Mining operates mining properties in British Columbia, Canada. The company’s principal Canadian gold exploration assets include the Snow Creek and Rosella Creek projects. Snow Creek consists of 498 acres, with approximately 80% being mineable; the Rosella Creek project covers 240 acres, with an estimated 90% being mineable. Three initial 100 cubic yard (100 yd3) test runs have been completed on the Snow Creek project, with results of 1.07, 1.08 and 1.12 ounces respectively. “The acquisition of the Snow Creek and Rosella Creek gold asset enhances the company’s long-term asset expansion plan and helps to derisk revenues, but most importantly, it complements our ammolite production with the world’s most sought-after commodity,” said GEMXX CEO Jay Maull in the press release. “This will provide GEMXX with a significant reduction in the cost of goods for our entire gold jewelry product line and will bring the Company one step closer to our goal of becoming vertically integrated.”

To view the full press release, visit https://ibn.fm/yRb2i

About GEMXX Corporation

GEMXX Corporation is a publicly traded, mine-to-market gemstone, gold and jewelry producer with global reach that owns mining resources, production facilities and operating assets. GEMXX controls each stage of its production including gold mining, gemstone production, jewelry manufacturing and global distribution. GEMXX is a producer of top-quality finished Ammolite and Ammolite jewelry. The company’s world-class gemstone cutters and jewelry designers are continuously leading the Ammolite industry in new and exciting directions. The company’s management team is made up of the industry’s leading experts with a combined total of 160 years of Ammolite gemstone and jewelry business experience. For more information about this company, please visit www.GEMXX.com.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork.

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

TinyGemsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Vision in Action: Building the Grid of Tomorrow

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a…

3 days ago

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Clearance to Begin Trials for CLD-201 in Solid Tumors

Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201,…

3 days ago

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Secures Military Contract Extension for Iridium PTT Services

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced that its subsidiary, Global Telesat Communications…

5 days ago

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Secures EV Van Sale to Global Expert Shipping

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced the sale of its all-electric Mullen…

6 days ago

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Halts Some U.S. Product Plans in China Over Tariff Escalation

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced it will pause select initiatives within…

6 days ago

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Appoints Oncology Expert Dr. Guy Travis Clifton as Chief Medical Officer

Calidi Biotherapeutics (NYSE American: CLDI) has named Dr. Guy Travis Clifton as Chief Medical Officer,…

1 week ago